Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Raphael
W Middleton

Showing results (371-380 of 492) with videos related to

Pageof 50
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 20, 2007
Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature reviewE Piperkova, B Raphael, M Altinyay, et al.
Lancet (London, England)|December 8, 2004
Mental health in complex emergenciesR F Mollica, B Lopes Cardozo, H J Osofsky, et al.
Bulletin Des Societes D'Ophtalmologie De France|November 1, 1981
[Epidermoid cyst of the orbit]J P Romanet, M Mouillon, B Raphael, et al.
Skeletal Radiology|February 1, 1994
Coraco-clavicular joint: normal variant in humans. A radiographic demonstration in the human and non-human primateN Haramati, R A Cook, B Raphael, et al.
Expert Review of Vaccines|September 9, 2010
Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancerV E Shaw, D J Naisbitt, E Costello, et al.
British Medical Journal (Clinical Research Ed.)|February 18, 1984
Analysis of T cell subsets in Graves' disease: alterations associated with carbimazoleM E Ludgate, A M McGregor, A P Weetman, et al.
Oncoscience|June 23, 2015
Methylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancerAndrew D Beggs, Mark P Dilworth, Enric Domingo, et al.
Biochemical Pharmacology|February 15, 1991
Fluorescent markers for hypoxic cells. A study of novel heterocyclic compounds that undergo bio-reductive bindingR J Hodgkiss, A C Begg, R W Middleton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesotheliomaG W Middleton, I E Smith, M E O'Brien, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 21, 2015
Cell-specific activity-dependent fractionation of layer 2/3→5B excitatory signaling in mouse auditory cortexAnkur Joshi, Jason W Middleton, Charles T Anderson, et al.
Pageof 50

Showing results (371-380 of 492) with videos related to

Sort By:
Pageof 50
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 20, 2007
Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature reviewE Piperkova, B Raphael, M Altinyay, et al.
Lancet (London, England)|December 8, 2004
Mental health in complex emergenciesR F Mollica, B Lopes Cardozo, H J Osofsky, et al.
Bulletin Des Societes D'Ophtalmologie De France|November 1, 1981
[Epidermoid cyst of the orbit]J P Romanet, M Mouillon, B Raphael, et al.
Skeletal Radiology|February 1, 1994
Coraco-clavicular joint: normal variant in humans. A radiographic demonstration in the human and non-human primateN Haramati, R A Cook, B Raphael, et al.
Expert Review of Vaccines|September 9, 2010
Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancerV E Shaw, D J Naisbitt, E Costello, et al.
British Medical Journal (Clinical Research Ed.)|February 18, 1984
Analysis of T cell subsets in Graves' disease: alterations associated with carbimazoleM E Ludgate, A M McGregor, A P Weetman, et al.
Oncoscience|June 23, 2015
Methylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancerAndrew D Beggs, Mark P Dilworth, Enric Domingo, et al.
Biochemical Pharmacology|February 15, 1991
Fluorescent markers for hypoxic cells. A study of novel heterocyclic compounds that undergo bio-reductive bindingR J Hodgkiss, A C Begg, R W Middleton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesotheliomaG W Middleton, I E Smith, M E O'Brien, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 21, 2015
Cell-specific activity-dependent fractionation of layer 2/3→5B excitatory signaling in mouse auditory cortexAnkur Joshi, Jason W Middleton, Charles T Anderson, et al.
Pageof 50